Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited

Published:2014-08 Issue:1 Volume:1846 Page:201-215
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Lupo Barbara,Trusolino Livio

Funder

AIRC

AIRC Investigator Grants

Fondazione Piemontese per la Ricerca sul Cancro-ONLUS

5x1000 Ministero della Salute 2011

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference205 articles.

1. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme;Chambon;Biochem. Biophys. Res. Commun.,1963

2. The PARP superfamily;Amé;Bioessays,2004

3. Poly(ADP-ribose): novel functions for an old molecule;Schreiber;Nat. Rev. Mol. Cell Biol.,2006

4. Beyond DNA repair: additional functions of PARP-1 in cancer;Weaver;Front. Oncol.,2013

5. Toward a unified nomenclature for mammalian ADP-ribosyltransferases;Hottiger;Trends Biochem. Sci.,2010

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing;World Journal of Oncology;2024-08

2. Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells;Epigenetics;2024-05-26

3. PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma;Journal of Experimental & Clinical Cancer Research;2024-02-21

4. PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair;The EMBO Journal;2024-02-15

5. Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation;DARU Journal of Pharmaceutical Sciences;2023-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3